New findings from Spherix Global Insights’ Patient Chart Dynamix™: Lupus Nephritis (US), 2025 report reveal a treatment landscape in transition as specialists increasingly incorporate biologics, ...

Benlysta (belimumab) is a biologic developed by Human Genome Sciences in partnership with GlaxoSmithKline (GSK). A biologic is a large, complex molecule that is produced using recombinant DNA ...

Initial uptake reflects strong efficacy-driven positioning relative to established therapies, though familiarity gaps, payer ...

Lupus drug Benlysta, developed by GlaxoSmithKline (NYSE:GSK) and drug partner Human Genome Sciences (NASDAQ:HGSI), can now count Canada among the markets where it will offer the first new lupus ...

Please provide your email address to receive an email when new articles are posted on . In the 10 years since its first FDA approval for systemic lupus erythematosus in 2011, belimumab has altered the ...

WASHINGTON (CBSNewYork.com/AP) The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in over 50 years, a milestone that medical ...

Benlysta (belimumab) is a prescription drug that’s used to help manage certain types of lupus. It’s not known whether Benlysta is safe to use while pregnant or breastfeeding. If you can become ...

GlaxoSmithKline is buying Human Genome Sciences for $3.6 billion, giving it full ownership of Benlysta, along with albiglutide and darapladib, after months of M&A intrigue. “We are pleased to have ...

Aiden Gallagher started developing symptoms of lupus at age 11 after a spider bite that left her hand swollen for weeks. Gallagher, now 18, took strong doses of the steroid prednisone to help control ...

WASHINGTON - The Food and Drug Administration on Wednesday approved the first new drug to treat lupus in over 50 years, a milestone that medical experts say could prompt development of other drugs ...

If you can become pregnant, it’s important to consider whether Benlysta is a safe choice for you. Monoclonal antibodies, such as belimumab (the active drug in Benlysta), may affect the immune system ...